Clinical analysis of 12 cases of pediatric myelodysplastic syndrome
Wei-ming Lin,Li Zhang,H. Lian,Rui Zhang,Yan Su,L. Jin,Jun J. Yang,G. Zhu,Jin Jiang
DOI: https://doi.org/10.3760/CMA.J.ISSN.2095-428X.2015.03.009
2015-02-05
Abstract:Objective
To summarize the characteristics of pediatric myelodysplastic syndrome(MDS), and provide the basis for further standardize diagnosis and treatment, through retrospective collection of children's myelodysplastic syndrome clinical features, laboratory tests, treatment and outcome data.
Methods
Twelve children diagnosed as MDS in Hematology Oncology Center, Beijing Children's Hospital Affiliated to Capital Medical University between January 2012 and December 2013 were enrolled in the study.Clinical symptoms, signs, laboratory examinations, treatment and outcomes were retrospectively studied.
Results
Twelve children(7 male and 5 female)with a median age of 9 years (range 4-14 years old)were identified.Clinical featurers: the average duration of disease history was 2 months(ranging from 0.5 to 5.0 months). The main clinical manifestations were anemia(10 cases, 83.3%), bleeding(4 cases, 33.3%), hepatosplenomegaly(3 cases, 25.0%), fever (2 cases, 16.7%), special rash (2 cases, 16.7%). Laboratory tests: complete blood count showed two lineages (75.0%) or three lineages(25.0%) reduced, and the anemia, thrombocytopenia were dominant.Bone marrow proliferation mostly demonstrated as active(11/12 cases, 91.7%). Dysplasia was significant in bone marrow, three lineages of hematopoietic dysplasia were observed in 6 patients(50.0%), and two lineages of hematopoietic dysplasia in 5 patients(41.7%). Alkal hemoglobin(Hb-F) was elevated, the me-dian 0.120 0 (ranging from 0.030 0~0.197 6). Small megakaryocytes enzyme prompted the median of small megakaryocytes percentage was 0.05 to 0.88, of which 8 cases (66.7%)more than 0.30; 50.0% abnormal karyotype analysis showed dominat chromosome abnormalities.Treatment and outcome: clinical observation of 12 patients for 1 year indicated that 3 patients were suitable for donor, and then received hematopoietic stem cell transplantation, 1 patient died of transplantation complications, and the other 2 cases survived; 7 cases of patients with supportive treatment only, 4 cases survived now, and the other 3 cases converted into acute myeloid leukemia, median time of conversion was 7 months, 1 case of the 3 patients died due to severe infection after chemotherapy, and the other 2 patients survived.1 patient left hospital after diagnosis and 1 patient abandoned treatment.
Conclusions
Pediatric MDS is characterized by acute onset, short disease history, lack of typical clinical manifestations, and a high rate of conversion to leukemia.Complete blood count showed cytopenia.Bone marrow proliferation is mainly active, and hematopoietic dysplasia is significant.Alkali hemoglobin, percentage of small megakaryocytes was elevated.Hematopoietic stem cell transplantation may be an effective treatment for pediatric MDS.
Key words:
Myelodysplastic syndrome; Child; Diagnosis; Treatment
Medicine